Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Haploidentical Peripheral Blood Stem Cell Transplantation (Haplo-PBSCT) with Cyclophosphamide Pos Transplant (CyPost) in High-Risk Hematologic Malignancies. Results of 5 Years in Transplant Center in Northeast of Mexico

Blood (2021) 138 (Supplement 1): 4860.

https://doi.org/10.1182/blood-2021-147359

Published: 2021

Journal Articles

Can the Autologous Transplant of Hematopoyetic Progenitors be Considered an Effective Alternative to Increase Global Survival in High-Grade Non-Hodgkin Lymphomas?

Alba Nydia Ramirez Lopez, MD, Enrique Baez De La Fuente, MD, Rosa Elva De Leon Cantu, MD, Diego Cruz Contreras, MD, Jose Alfredo Carrizalez Villarreal, MD, Jose Luis Cedillo De La Cerda, Roxana Saldaña Vazquez, MD, Helga Patricia Sorkee Davila, MD, Axel Eduardo Rosas Rodríguez, MD, Severiano Baltazar Arellano, MD, Roberto Hernandez Valdes, MD, Bernardo Lafarga Amao, RESIDENTE, Rosa Lozano, MD, Andrea Terrazas, MD

Blood (2017) 130 (Supplement 1): 5520.

https://doi.org/10.1182/blood.V130.Suppl_1.5520.5520

Published: 2017

Journal Articles

Mutations In Circadian Rhythm Genes Are Associated with Diffuse Large B-Cell Lymphoma In the Mexican Population

Miguel Ángel Gutiérrez-Monreal, MSc, Luis Villela, MD, Yocanxochitl Perfecto, MSc, Samuel Kettenhofen, Guy Cardineau, PhD, Severiano Baltazar, MD, Job Cortez, MD, Sean-Patrick Scott, PhD

Blood (2010) 116 (21): 2478.

https://doi.org/10.1182/blood.V116.21.2478.2478

Published: 2010

Journal Articles

Correlation between FOXP3 Gene Polymorphisms in Donors, and the Severity of Acute Graft-Versus-Host Disease in Patients after Related Allogeneic Stem Cell Transplantation.

Yocanxochitl Perfecto-Avalos, MSc, Jose R. Borbolla Escoboza, MD, Luis M. Villela-Martiez, MD, Sean P. Scott, PhD, Jorge Vela-Ojeda, MD, PhD, Oscar Gonzalez-Ramella, MD, PhD, Severiano Baltazar-Arellano, MD, Manuel A. Lopez-Hernandez, MD

Blood (2007) 110 (11): 3233.

https://doi.org/10.1182/blood.V110.11.3233.3233

Published: 2007

Journal Articles

Efficacy and Safety of Rituximab+CHOP in IR and Maintenance Therapy with Rituximab vs Observation in De Novo Aggressive Non-Hodgkin Lymphoma.

Francisco Tripp, MD, Enrique Báez, MD, Elsa Ávila, MD, Severiano Baltazar, MD, Oscar Garcés, MD, Gustavo Reyes, MD, Benjamín Batista, MD, Alva Zaragoza, MD, Jorge Vela-Ojeda, MD, Luis Villela, MD

Blood (2007) 110 (11): 4489.

https://doi.org/10.1182/blood.V110.11.4489.4489

Published: 2007

Journal Articles

Non Hodgkin Lymphoma (NHL) Distribution and Clinical Characteristics in a Mexican Registry with High Frequency of T Cell NHL: A Descriptive Study on Behalf of Mexican Hematology Study Group (MHSG).

Gregorio Ignacio, MD, Francisco Tripp, MD, Petty Rodríguez, MD, Mario Martínez, MD, Concepción Martínez, MD, Elsa Ávila, MD, Severiano Baltazar, MD, Alva Zaragoza, MD, Silvia Rivas, MD, Eduardo E. Reynoso, MD

Blood (2007) 110 (11): 4407.

https://doi.org/10.1182/blood.V110.11.4407.4407

Published: 2007

Journal Articles

Fludarabine and Mitoxantrone for the Refractory Relapse Treatment of B-Cell Low-Grade Non-Hodgkin Lymphoma (NHL): LACOHG First Interim Report (Latin American Cooperative Oncology Hematology Group) .

Severiano Baltazar-Arellano, MD, Patricia Pimentel, MD, Luis Vera, MD, Fernando Bezares, MD, Jose Málaga, MD, Julia Huamani-Z, PharmD, Antonio Montante, MD, Silvia Rivas-Vera, MD, Antonio A. Carrasco-Yalan, MD, Brady E. Beltran-Garate, MD

Blood (2006) 108 (11): 4665.

https://doi.org/10.1182/blood.V108.11.4665.4665

Published: 2006

Journal Articles

High Incidence of Bcl-2/IgH Rearrangement in Mexican Patients With Follicular Lymphoma and Its Relevance as a Marker for Minimal Residual Disease.

Rosa M. Arana, QFB, Pedro Sobrevilla-Calvo, MD, Silvia Rivas-Vera, MD, Enrique Baez, MD, Severiano Baltazar, MD, Jorge Duque, MD, Ignacio Gregorio, MD, Francisco Tripp, MD, Oscar Garces, MD, Luis Aguilar, MD, Luis Flores, MD

Blood (2005) 106 (11): 4493.

https://doi.org/10.1182/blood.V106.11.4493.4493

Published: 2005

Journal Articles

Is First Line Single Agent Rituximab the Best Treatment for Indolent Non-Hodgkin’s Lymphoma? Update of a Multicentric Study Comparing Rituximab vs CNOP vs Rituximab Plus CNOP.

Silvia Rivas-Vera, MD, Enrique Baez, MD, Pedro Sobrevilla-Calvo, MD, Severiano Baltazar, MD, Francisco Tripp, MD, Jorge Vela, MD, Oscar Garces, MD, Luis Aguilar, MD, Gregorio Ignacio, MD, Jorge Duque, MD, Petty Rodriguez, MD, Gustavo Reyes, MD

Blood (2005) 106 (11): 2431.

https://doi.org/10.1182/blood.V106.11.2431.2431

Published: 2005

Journal Articles

Clinical Results of a −80°C Simplified Cryo-Preservation Method.

Jose R. Borbolla Escoboza, MD, Manuel A. Lopez-Hernandez, MD, Marcos E. Garza, MD, Enrique Baez, MD, Elvira Trueba, MD, Roberto Hernandez, MD, Jose E. DeDiego-FloresChapa, MD, Severiano Baltazar, MD, Martha Alvarado, MD, Gerardo Villareal, MD, Mauricio C. Gonzalez-Avante, MD, Rosa E. De Leon, MD, Jose L. Cedillo, MD, Jason A. Penniecook, MD, Yara E. Tovar, MD, Maria I. Leon, Cecilia Ramirez-Assad, MD

Blood (2004) 104 (11): 5015.

https://doi.org/10.1182/blood.V104.11.5015.5015

Published: 2004

Journal Articles

Frequency of Genetic Deletions of the Glutathione-S Transferase (Gst) Gene in Mexican Patients with De Novo Acute Leukemia: A Preliminary Report from the “Instituto Tecnologico De Monterrey-Hematology Research Group”.

Blood (2004) 104 (11): 4312.

https://doi.org/10.1182/blood.V104.11.4312.4312

Published: 2004

NARROW

Haploidentical Peripheral Blood Stem Cell Transplantation (Haplo-PBSCT) with Cyclophosphamide Pos Transplant (CyPost) in High-Risk Hematologic Malignancies. Results of 5 Years in Transplant Center in Northeast of Mexico

Can the Autologous Transplant of Hematopoyetic Progenitors be Considered an Effective Alternative to Increase Global Survival in High-Grade Non-Hodgkin Lymphomas?

Mutations In Circadian Rhythm Genes Are Associated with Diffuse Large B-Cell Lymphoma In the Mexican Population

Correlation between FOXP3 Gene Polymorphisms in Donors, and the Severity of Acute Graft-Versus-Host Disease in Patients after Related Allogeneic Stem Cell Transplantation.

Efficacy and Safety of Rituximab+CHOP in IR and Maintenance Therapy with Rituximab vs Observation in De Novo Aggressive Non-Hodgkin Lymphoma.

Non Hodgkin Lymphoma (NHL) Distribution and Clinical Characteristics in a Mexican Registry with High Frequency of T Cell NHL: A Descriptive Study on Behalf of Mexican Hematology Study Group (MHSG).

Fludarabine and Mitoxantrone for the Refractory Relapse Treatment of B-Cell Low-Grade Non-Hodgkin Lymphoma (NHL): LACOHG First Interim Report (Latin American Cooperative Oncology Hematology Group) .

High Incidence of Bcl-2/IgH Rearrangement in Mexican Patients With Follicular Lymphoma and Its Relevance as a Marker for Minimal Residual Disease.

Is First Line Single Agent Rituximab the Best Treatment for Indolent Non-Hodgkin’s Lymphoma? Update of a Multicentric Study Comparing Rituximab vs CNOP vs Rituximab Plus CNOP.

Clinical Results of a −80°C Simplified Cryo-Preservation Method.

Frequency of Genetic Deletions of the Glutathione-S Transferase (Gst) Gene in Mexican Patients with De Novo Acute Leukemia: A Preliminary Report from the “Instituto Tecnologico De Monterrey-Hematology Research Group”.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only